Influence of CYP2C19 and CYP3A5 polymorphisms on tacrolimus pharmacokinetics in the combination therapy with lansoprazole in Japanese renal transplant recipients
Influence of CYP2C19 and CYP3A5 polymorphisms on tacrolimus pharmacokinetics in the combination therapy with lansoprazole in Japanese renal transplant recipients
复制标题
CYP2C19和CYP3A5多态性对他克莫司与兰索拉唑联合治疗日本肾移植受者药代动力学的影响
DOI：
--
复制
发表时间：
2018
期刊：
影响因子：
--
通讯作者：
Yano I
中科院分区：
文献类型：
--
作者：
Yamamoto K;Iida M;Yoshida A;to T;Yokoyama N;Ishimura T;Fujisawa M;Yano I
